India has begun the world's largest vaccination drive, as it gears up to carry out 300,000 inoculations a day

India COVID vaccine push January 16 2020.JPG
A healthcare worker reacts as she receives a dose of Covishield, a COVID-19 vaccine manufactured by Serum Institute of India.

India on Saturday began what is expected to be the world's largest COVID-19 vaccination drive, with a goal of about 300,000 people a day. 

The country set up more 3,000 vaccine stations, aiming to inoculate 100 people per day at each, according to local reports.  

About 165,714 people were vaccinated by Saturday evening, according to The Associated Press. A few hours later, the total climbed to about 191,181, according to The Times of India

Many of those vaccinated Saturday were frontline healthcare workers, according to The Hindu

"This is a day of pride, a celebration of the prowess of our scientists and hard work of our medical fraternity, nursing staff, police personnel and sanitation workers. May everyone be healthy and free from illness," Narendra Modi, India's prime minister, wrote on Twitter using the hashtag #LargestVaccineDrive.

With about 1.4 billion people, India is the world's second most populous country.

 

In the year since the pandemic began, about 152,093 people have died in India, according to Johns Hopkins University. The country has had about 10.5 million cases. Only the US has had more cases than India, per AP. 

More than 2 million people had died worldwide, as of Friday. There have been about 94 million cases worldwide, according to Johns Hopkins

AstraZeneca's COVID-19 vaccine was approved for emergency use in India on January 3, along with a local alternative. 

AstraZeneca's regional manufacturing partner, Serum Institute of India, is producing the drug in India, according to CEO Adar Poonawalla. AstraZeneca's drug is locally called Covishield. 

On Saturday, Poonawalla posted a video of himself receiving the vaccine.  "It brings me great pride that #COVISHIELD is part of this historic effort & to endorse its safety & efficacy," he wrote. 

Read the original article on Business Insider


from Business Insider https://ift.tt/2LUoEUn

No comments

Powered by Blogger.